Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R E Jones

Showing results (331-340 of 338) with videos related to

Pageof 34
Sort By:
You have reached the last page of results.This site can display upto 338 results.
The Journal of Biological Chemistry|January 15, 1992
Specific N-methylations of HPV-16 E7 peptides alter binding to the retinoblastoma suppressor proteinR E Jones, D C Heimbrook, H E Huber, et al.
Journal of Neuroscience Research|June 1, 1993
Treatment of relapsing experimental autoimmune encephalomyelitis with T cell receptor peptidesR H Whitham, B L Kotzin, A C Buenafe, et al.
Plant Biology (Stuttgart, Germany)|September 18, 2004
Changes in vegetation and soil characteristics in coastal sand dunes along a gradient of atmospheric nitrogen depositionM L M Jones, H L Wallace, D Norris, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|November 7, 2000
Osteonecrosis in HIV: a case-control studyA N Scribner, P V Troia-Cancio, B A Cox, et al.
Journal of Medicinal Chemistry|November 16, 2001
The synthesis of a prodrug of doxorubicin designed to provide reduced systemic toxicity and greater target efficacyV M Garsky, P K Lumma, D M Feng, et al.
Journal of Virology|February 1, 1993
Papillomavirus E7 protein binding to the retinoblastoma protein is not required for viral induction of wartsD Defeo-Jones, G A Vuocolo, K M Haskell, et al.
The Journal of Biological Chemistry|August 5, 1990
Identification of HPV-16 E7 peptides that are potent antagonists of E7 binding to the retinoblastoma suppressor proteinR E Jones, R J Wegrzyn, D R Patrick, et al.
Nature Medicine|November 4, 2000
A peptide-doxorubicin 'prodrug' activated by prostate-specific antigen selectively kills prostate tumor cells positive for prostate-specific antigen in vivoD DeFeo-Jones, V M Garsky, B K Wong, et al.
Pageof 34

Showing results (331-340 of 338) with videos related to

Sort By:
Pageof 34
You have reached the last page of results.This site can display upto 338 results.
The Journal of Biological Chemistry|January 15, 1992
Specific N-methylations of HPV-16 E7 peptides alter binding to the retinoblastoma suppressor proteinR E Jones, D C Heimbrook, H E Huber, et al.
Journal of Neuroscience Research|June 1, 1993
Treatment of relapsing experimental autoimmune encephalomyelitis with T cell receptor peptidesR H Whitham, B L Kotzin, A C Buenafe, et al.
Plant Biology (Stuttgart, Germany)|September 18, 2004
Changes in vegetation and soil characteristics in coastal sand dunes along a gradient of atmospheric nitrogen depositionM L M Jones, H L Wallace, D Norris, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|November 7, 2000
Osteonecrosis in HIV: a case-control studyA N Scribner, P V Troia-Cancio, B A Cox, et al.
Journal of Medicinal Chemistry|November 16, 2001
The synthesis of a prodrug of doxorubicin designed to provide reduced systemic toxicity and greater target efficacyV M Garsky, P K Lumma, D M Feng, et al.
Journal of Virology|February 1, 1993
Papillomavirus E7 protein binding to the retinoblastoma protein is not required for viral induction of wartsD Defeo-Jones, G A Vuocolo, K M Haskell, et al.
The Journal of Biological Chemistry|August 5, 1990
Identification of HPV-16 E7 peptides that are potent antagonists of E7 binding to the retinoblastoma suppressor proteinR E Jones, R J Wegrzyn, D R Patrick, et al.
Nature Medicine|November 4, 2000
A peptide-doxorubicin 'prodrug' activated by prostate-specific antigen selectively kills prostate tumor cells positive for prostate-specific antigen in vivoD DeFeo-Jones, V M Garsky, B K Wong, et al.
Pageof 34